In our study, we first found the SGOL2 maybe a novel diagnostic marker in HCC, then we predicted that SGOL2 may exert its function through MAD2, which was demonstrated by vitro and vivo experiments. The gene discussed is SGO2; the disease is hepatocellular carcinoma.